| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Feb―08 |
RBD-displaying OMV nanovaccine boosts immunity against SARS-CoV-2 |
Rang Feng, Ruo-Yi Xue, Chang Liu, Guo-Cheng Li, Yan Deng, Zhe Jin, Jing-Yi Liu, Shan-Shan Zhang, Hao Cheng, Man-Ying Guo, Quan-Ming Zou, Hai-Bo Li |
| 2 |
[GO] |
2025―Jan―24 |
Fc-binding nanodisc restores antiviral efficacy of antibodies with reduced neutralizing effects against evolving SARS-CoV-2 variants |
Jaehyeon Hwang, Soyun Choi, Beom Kyu Kim, Sumin Son, Jeong Hyeon Yoon, Kyung Won Kim, Wonbeom Park, Hyunjoo Choo, Suhyun Kim, Soomin Kim, Seokhyeon Yu, Sangwon Jung, Sang Taek Jung, Min-Suk Song, Sang Jick Kim, Dae-Hyuk Kweon |
| 3 |
[GO] |
2025―Jan―15 |
Lipid-encapsulated gold nanoparticles: an advanced strategy for attenuating the inflammatory response in SARS-CoV-2 infection |
Sanjeevram Dhandapani, Yujeong Ha, Rongbo Wang, Tae Woo Kwon, Ik-Hyun Cho, Yeon-Ju Kim |
| 4 |
[GO] |
2024―Jul―02 |
Nanobody peptide conjugate: a novel CD163 based broad neutralizing strategy against porcine reproductive and respiratory syndrome virus |
Haotian Yang, Meiqi Sun, He Qiu, Huiling Xu, Zhuofan Deng, Han Gu, Nan Wang, Liuyang Du, Fushan Shi, Jiyong Zhou, Fang He |
| 5 |
[GO] |
2024―Mai―31 |
Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses |
Yang Yang, Fang Li, Lanying Du |
| 6 |
[GO] |
2024―Apr―12 |
Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19 |
Jia-You Fang, Kuo-Yen Huang, Tong-Hong Wang, Zih-Chan Lin, Chin-Chuan Chen, Sui-Yuan Chang, En-Li Chen, Tai-Ling Chao, Shuenn-Chen Yang, Pan-Chyr Yang, Chi-Yuan Chen |
| 7 |
[GO] |
2024―Feb―27 |
Inhalable hybrid nanovaccines with virus-biomimetic structure boost protective immune responses against SARS-CoV-2 variants |
Shuqi Wang, Peiyang Ding, Lingli Shen, Daopeng Fan, Hanghang Cheng, Jian Huo, Xin Wei, Hua He, Gaiping Zhang |
| 8 |
[GO] |
2024―Feb―10 |
Computational design and engineering of self-assembling multivalent microproteins with therapeutic potential against SARS-CoV-2 |
Qin Qin, Xinyi Jiang, Liyun Huo, Jiaqiang Qian, Hongyuan Yu, Haixia Zhu, Wenhao Du, Yuhui Cao, Xing Zhang, Qiang Huang |
| 9 |
[GO] |
2024―Jan―30 |
Double-layered N-S1 protein nanoparticle immunization elicits robust cellular immune and broad antibody responses against SARS-CoV-2 |
Ruiqi Li, Zejie Chang, Hongliang Liu, Yanan Wang, Minghui Li, Yilan Chen, Lu Fan, Siqiao Wang, Xueke Sun, Siyuan Liu, Anchun Cheng, Peiyang Ding, Gaiping Zhang |
| 10 |
[GO] |
2024―Jan―03 |
Nano-carrier DMSN for effective multi-antigen vaccination against SARS-CoV-2 |
Peng Sun, Bingsheng Cheng, Jiaxi Ru, Xiaoyan Li, Guicun Fang, Yinli Xie, Guangjiang Shi, Jichao Hou, Longwei Zhao, Lipeng Gan, Lina Ma, Chao Liang, Yin Chen, Zhiyong Li |
| 11 |
[GO] |
2024―Jan―03 |
Novel enzyme-linked aptamer-antibody sandwich assay and hybrid lateral flow strip for SARS-CoV-2 detection |
Shih-Wei Wu, Ying-Ju Chen, Yu-Wen Chang, Cheng-Yang Huang, Biing-Hui Liu, Feng-Yih Yu |
| 12 |
[GO] |
2023―Aug―04 |
Metallic nanoplatforms for COVID-19 diagnostics: versatile applications in the pandemic and post-pandemic era |
Yuqing Li, Jingqi Chen, Jinchao Wei, Xueliang Liu, Lu Yu, Linqi Yu, Ding Ding, Yu Yang |
| 13 |
[GO] |
2023―Jun―21 |
Utilizing nanozymes for combating COVID-19: advancements in diagnostics, treatments, and preventative measures |
Jia Wang, Qingpeng Xie, Haoyue Song, Xiaohang Chen, Xiaoxuan Zhang, Xiangyu Zhao, Yujia Hao, Yuan Zhang, Huifei Li, Na Li, Kelong Fan, Xing Wang |
| 14 |
[GO] |
2023―Jun―21 |
Nanostructures for prevention, diagnosis, and treatment of viral respiratory infections: from influenza virus to SARS-CoV-2 variants |
Esmaeel Sharifi, Satar Yousefiasl, Maria Trovato, Rossella Sartorius, Yasaman Esmaeili, Hamid Goodarzi, Matineh Ghomi, Ashkan Bigham, Farnaz Dabbagh Moghaddam, Maryam Heidarifard, Samiramis Pourmotabed, Ehsan Nazarzadeh Zare, Ana Cláudia Paiva-Santos, Navid Rabiee, Xiangdong Wang, Franklin R. Tay |
| 15 |
[GO] |
2023―Mai―19 |
Detoxified synthetic bacterial membrane vesicles as a vaccine platform against bacteria and SARS-CoV-2 |
Kyong-Su Park, Kristina Svennerholm, Rossella Crescitelli, Cecilia Lässer, Inta Gribonika, Mickael Andersson, Jonas Boström, Hanna Alalam, Ali M Harandi, Anne Farewell, Jan Lötvall |
| 16 |
[GO] |
2023―Apr―29 |
CRISPR-Cas13a-powered electrochemical biosensor for the detection of the L452R mutation in clinical samples of SARS-CoV-2 variants |
Zhi Chen, Chenshuo Wu, Yuxuan Yuan, Zhongjian Xie, Tianzhong Li, Hao Huang, Shuang Li, Jiefeng Deng, Huiling Lin, Zhe Shi, Chaozhou Li, Yabin Hao, Yuxuan Tang, Yuehua You, Omar A. Al-Hartomy, Swelm Wageh, Abdullah G. Al-Sehemi, Ruitao Lu, Ling Zhang, Xuechun Lin, Yaqing He, Guojun Zhao, Defa Li, Han Zhang |
| 17 |
[GO] |
2023―Feb―22 |
Enhanced mucosal immune responses and reduced viral load in the respiratory tract of ferrets to intranasal lipid nanoparticle-based SARS-CoV-2 proteins and mRNA vaccines |
Patricia A. Boley, Carolyn M. Lee, Jennifer Schrock, Kush Kumar Yadav, Veerupaxagouda Patil, Raksha Suresh, Songqing Lu, Maoqi Mark Feng, Juliette Hanson, Rudra Channappanavar, Scott P. Kenney, Gourapura J. Renukaradhya |
| 18 |
[GO] |
2022―Dez―15 |
Multiplexed evaluation of immunity against SARS-CoV-2 variants using surface enhanced fluorescence from a nanostructured plasmonic chip |
Ruibin Hu, Yang Yang, Ying Liu, Tao Liao, Yiyi Liu, Jiahu Tang, Guanghui Wang, Guoxin Wang, Yongye Liang, Jing Yuan, Bo Zhang |
| 19 |
[GO] |
2022―Okt―08 |
An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19 |
Saman Yasamineh, Hesam Ghafouri Kalajahi, Pooneh Yasamineh, Yalda Yazdani, Omid Gholizadeh, Raheleh Tabatabaie, Hamed Afkhami, Fatemeh Davodabadi, Alireza Khanalipour farkhad, Daryoush Pahlevan, Akram Firouzi-Amandi, Kazem Nejati-Koshki, Mehdi Dadashpour |
| 20 |
[GO] |
2022―Sep―15 |
A potent synthetic nanobody with broad-spectrum activity neutralizes SARS-CoV-2 virus and the Omicron variant BA.1 through a unique binding mode |
Dongping Zhao, Liqin Liu, Xinlin Liu, Jinlei Zhang, Yuqing Yin, Linli Luan, Dingwen Jiang, Xiong Yang, Lei Li, Hualong Xiong, Dongming Xing, Qingbing Zheng, Ningshao Xia, Yuyong Tao, Shaowei Li, Haiming Huang |
| 21 |
[GO] |
2022―Sep―05 |
Immunomolecular assay based on selective virion capture by spike antibody and viral nucleic acid amplification for detecting intact SARS-CoV-2 particles |
Xiaoli Wu, Junye Liu, Hongpeng Zhang, Hua Zhou, Wen Wang, Yuanyan Ma, Shimei Shen, Xuefei Cai, Ailong Huang, Deqiang Wang |
| 22 |
[GO] |
2022―Jul―30 |
Iron oxide and iron oxyhydroxide nanoparticles impair SARS-CoV-2 infection of cultured cells |
Marta L. DeDiego, Yadileiny Portilla, Neus Daviu, Darío López-García, Laura Villamayor, Vladimir Mulens-Arias, Jesús G. Ovejero, Álvaro Gallo-Cordova, Sabino Veintemillas-Verdaguer, M. Puerto Morales, Domingo F. Barber |
| 23 |
[GO] |
2022―Jun―07 |
Polymerized porin as a novel delivery platform for coronavirus vaccine |
Zhongqian Yang, Liangqun Hua, Mengli Yang, Weiran Li, Zhaoling Ren, Xiao Zheng, Haoqian Chen, Qiong Long, Hongmei Bai, Weiwei Huang, Yanbing Ma |
| 24 |
[GO] |
2022―Feb―05 |
Inhibitory effect and mechanism of gelatin stabilized ferrous sulfide nanoparticles on porcine reproductive and respiratory syndrome virus |
Ting Tong, Shuangfei Deng, Xiaotong Zhang, Liurong Fang, Jiangong Liang, Shaobo Xiao |
| 25 |
[GO] |
2021―Nov―30 |
Nanovesicles derived from bispecific CAR-T cells targeting the spike protein of SARS-CoV-2 for treating COVID-19 |
Tianchuan Zhu, Yuchen Xiao, Xiaojun Meng, Lantian Tang, Bin Li, Zhaoyan Zhao, Qingqin Tan, Hong Shan, Lei Liu, Xi Huang |
| 26 |
[GO] |
2021―Okt―07 |
The promising use of nano-molecular imprinted templates for improved SARS-CoV-2 detection, drug delivery and research |
Alaa F. Nahhas, Thomas J. Webster |
| 27 |
[GO] |
2021―Sep―08 |
Application of the amplification-free SERS-based CRISPR/Cas12a platform in the identification of SARS-CoV-2 from clinical samples |
Jiajie Liang, Peijun Teng, Wei Xiao, Guanbo He, Qifang Song, Ying Zhang, Bin Peng, Gan Li, Liangshan Hu, Donglin Cao, Yong Tang |
| 28 |
[GO] |
2021―Jun―10 |
Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19 |
Qingqin Tan, Lingjie He, Xiaojun Meng, Wei Wang, Hudan Pan, Weiguo Yin, Tianchuan Zhu, Xi Huang, Hong Shan |
| 29 |
[GO] |
2021―Jan―29 |
Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein |
Qizhong Lu, Zongliang Zhang, Hexian Li, Kunhong Zhong, Qin Zhao, Zeng Wang, Zhiguo Wu, Donghui Yang, Shuang Sun, Nian Yang, Meijun Zheng, Qiang Chen, Cheng Long, Wenhao Guo, Hui Yang, Chunlai Nie, Aiping Tong |
| 30 |
[GO] |
2020―Sep―05 |
How can nanotechnology help to combat COVID-19? Opportunities and urgent need |
Estefânia V. R. Campos, Anderson E. S. Pereira, Jhones Luiz de Oliveira, Lucas Bragança Carvalho, Mariana Guilger-Casagrande, Renata de Lima, Leonardo Fernandes Fraceto |
|
